| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 76006 |
DOTA-4Py 螯合剂DOTA偶联吡啶基4Py |
71 |
h |
2024-12-19 |
| 76007 |
钆喷酸葡胺(Gd-BOPTA) |
199 |
h |
2024-12-19 |
| 76008 |
DOTA-SA-mAb |
77 |
h |
2024-12-19 |
| 76009 |
(LLP2A-DOTA)(4)PEG(10000) |
73 |
h |
2024-12-19 |
| 76010 |
LLP2A-DOTA-聚乙二醇 LLP2A-DOTA-PEG |
69 |
h |
2024-12-19 |
| 76011 |
DOTA-AaLS/HER2Afb HER2Afb修饰DOTA缀合的AaLS-ST |
85 |
h |
2024-12-19 |
| 76012 |
DOTA-P4 Thz-Phe-D-Trp-Lys-Thr-DOTA DOTA的线型超短肽缀合物 |
98 |
h |
2024-12-19 |
| 76013 |
DOTA-BP DOTA偶联双膦酸盐 |
120 |
h |
2024-12-19 |
| 76014 |
DOTA缀合的p160肽基放射缀合物 DOTA-p160 |
99 |
h |
2024-12-19 |
| 76015 |
DOTA-氮氧化合物 DOTA-NOx |
85 |
h |
2024-12-19 |
| 76016 |
Er-DOTA 铒-DOTA配合物 |
91 |
h |
2024-12-19 |
| 76017 |
DOTA-SETSKSF DOTA偶联七个氨基酸残基组成的环肽抑制剂 |
133 |
h |
2024-12-19 |
| 76018 |
羧基Bn-DOTA p-COOH-Bn-DOTA |
83 |
h |
2024-12-19 |
| 76019 |
DOTA四酰肼钆(ⅲ)配合物 |
85 |
h |
2024-12-19 |
| 76020 |
3-Gd(III)-氨基乙基酰胺基-DOTA的缀合物 |
109 |
h |
2024-12-19 |
| 76021 |
TCO功能化的CC49抗体 TCO-CC49 |
188 |
h |
2024-12-19 |
| 76022 |
CLT1肽靶向Gd(III)螯合物 CLT1-dL-(Gd-DOTA) |
113 |
h |
2024-12-19 |
| 76023 |
DOTA-pNO(2)-Phe-c(DCys-Tyr-DTrp-Lys-Thr-Cys)DTyrNH |
127 |
h |
2024-12-19 |
| 76024 |
Gd-DOTA-PLGA-b-PEG 钆-四氮杂环十二烷四乙酸共轭的聚(乳酸-共-乙醇酸)-嵌段-聚(乙二醇)共聚物胶束 |
119 |
h |
2024-12-19 |
| 76025 |
DOTA聚乙二醇化星形共聚物纳米粒子 |
89 |
h |
2024-12-19 |
| 76026 |
镓-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-Leu-Thr-Val-Ser-Pro-Trp-Tyr |
116 |
h |
2024-12-19 |
| 76027 |
DOTA-C595 p-SCN-Bn-DOTA偶联C595抗体 |
142 |
h |
2024-12-19 |
| 76028 |
DOTA-Tyr3-奥曲肽 DOTA-Tyr3-TOC |
87 |
h |
2024-12-19 |
| 76029 |
DOTA-生物素-亲和素 DOTA-biotin-avidin |
62 |
h |
2024-12-19 |
| 76030 |
DOTA-AuNPs 螯合剂DOTA包覆金纳米颗粒 |
100 |
h |
2024-12-19 |
| 76031 |
PS-WSCS-DOTA-BBN 水溶性壳聚糖缀合的DOTA-铃蟾肽包覆的金纳米颗粒 |
79 |
h |
2024-12-19 |
| 76032 |
苄基DOTA Bn-DOTA |
193 |
h |
2024-12-19 |
| 76033 |
DOTA-LM3 生长抑素受体(SSTR)拮抗剂 |
103 |
h |
2024-12-19 |
| 76034 |
Ga-DOTA-MGS5 大环配体-靶向肽 |
99 |
h |
2024-12-19 |
| 76035 |
Re-cyc-DOTA-sst2-ANT复合物 |
98 |
h |
2024-12-19 |
| 76036 |
DOTA-SP DOTA-P物质(SP) |
107 |
h |
2024-12-19 |
| 76037 |
DOTA-MG45 DOTA偶联迷你胃泌素(MG45) |
105 |
h |
2024-12-19 |
| 76038 |
DOTA-甘露糖胺葡聚糖 DOTA-MADs |
85 |
h |
2024-12-19 |
| 76039 |
ICG-DOTA 大环配体DOTA修饰吲哚菁绿荧光染料 |
103 |
h |
2024-12-18 |
| 76040 |
DOTA-SSA 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)-生长抑素类似物(SSA) |
84 |
h |
2024-12-18 |
| 76041 |
DOTA螯合剂修饰[cPP(1-7) |
143 |
h |
2024-12-18 |
| 76042 |
DOTA-ALB-24 DOTA-4-(对碘苯基)丁酸酯-24 |
94 |
h |
2024-12-18 |
| 76043 |
DOTA-GGNle-CycMSH hex DOTA偶联新肽 |
112 |
h |
2024-12-18 |
| 76044 |
Zr-p-NO2Bn-DOTA异构体 锆-硝基苄基偶联DOTA螯合剂 |
106 |
h |
2024-12-18 |
| 76045 |
DOTA-PSMA-617 1,4,7,10-四氮杂环十五烷偶联PSMA-617 |
83 |
h |
2024-12-18 |
| 76046 |
DOTA-VAP-1 螯合剂DOTA偶联VAP-1靶向肽 |
146 |
h |
2024-12-18 |
| 76047 |
DOTA-GIP-C803 DOTA螯合剂缀合GIPC803肽 |
75 |
h |
2024-12-18 |
| 76048 |
DOTA-mPS 螯合剂DOTA修饰微米级聚苯乙烯 |
105 |
h |
2024-12-18 |
| 76049 |
DOTA-HBED-bisphosphonate DOTA-HBED-二膦酸盐 |
102 |
h |
2024-12-18 |
| 76050 |
CAS号：2226472-28-0 ，DBCO-PEG4-Val-Cit-PAB-PNP |
105 |
WYQ |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询